AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

As the C language, which forms the basis of critical global software like operating systems, faces security limitations, ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Some residents in Burnaby, B.C., are concerned new multiplex homes aren't fitting into existing neighbourhoods. As Johna Baylon reports, city council has agreed the heights and sizes for future ...